VJHemOnc is committed to improving our service to you

COMy Virtual 2020 | Immunotherapies for the treatment of high-risk MM

VJHemOnc is committed to improving our service to you

Michael O'Dwyer

Michael O’Dwyer, MD, PhD, National University of Ireland, Galway, Ireland, talks on the treatment and prognosis of high-risk multiple myeloma (MM) patients and the importance of immunotherapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter